By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Antibody firm Epitomics today announced it has signed a contract with SAIC-Frederick to develop rabbit monoclonal antibodies in support of the National Cancer Institute's proteomics initiative.

SAIC-Frederick operates under a contract with NCI's Clinical Proteomic Technologies for Cancer program.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.